Doctor profile · Federal record
Dr. Ashley Fry, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Birmingham, AL
- NPI 1184941460
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2728 10Th Ave S Ste 200
Birmingham, AL 352051202
(205) 939-7880
fax (205) 939-2509 - Mailing address
-
500 Office Park Drive, Suite 400
Birmingham, AL 352232457
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alabama #MD.31349
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184941460. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
63,596
Distinct HCPCS
10
Medicare allowed
$457,151
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 50,490 | 49 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 6,060 | 32 | $23 | |
J1556 |
Injection, immune globulin (bivigam), 500 mg | 1,640 | 11 | $72 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,438 | 34 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,020 | 28 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 645 | 223 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 408 | 133 | $116 | |
J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 372 | 11 | $125 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 289 | 44 | $25 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 193 | 50 | $114 |
In context: peer comparison
Among 34 peers in Birmingham Hematology & Oncology Physician, average services per provider: 1,964. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$2,198
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $330.11 | |
| AstraZeneca Pharmaceuticals Lp | 9 | $176.56 | |
| Merck Sharp & Dohme LLC | 7 | $155.42 | |
| Genentech USA, INC. | 7 | $151.86 | |
| Abbvie INC. | 8 | $150.84 | |
| Sobi, INC | 8 | $142.81 | |
| Pfizer INC. | 8 | $130.42 | |
| Takeda Pharmaceuticals U.S.A., INC. | 5 | $105.06 | |
| Daiichi Sankyo INC. | 3 | $72.06 | |
| Genzyme Corporation | 3 | $67.29 | |
| Incyte Corporation | 3 | $64.64 | |
| PharmaEssentia USA Corporation | 3 | $55.33 | |
| Blueprint Medicines Corporation | 2 | $51.97 | |
| Deciphera Pharmaceuticals INC. | 2 | $50.66 | |
| Ipsen Biopharmaceuticals, INC | 2 | $47.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,066
Patients
344
Total drug cost
$58,988
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 319 | 81 | $12,173 |
| Ondansetron Hcl | Generic | 97 | 54 | $2,739 |
| Mirtazapine | Generic | 78 | 20 | $599 |
| Promethazine Hcl | Generic | 72 | 36 | $509 |
| Dexamethasone | Generic | 60 | 15 | $456 |
| Tamoxifen Citrate | Generic | 59 | 18 | $3,145 |
| Oxycodone Hcl | Generic | 56 | 18 | $777 |
| Lorazepam | Generic | 52 | 14 | $232 |
| Oxybutynin Chloride | Generic | 49 | 13 | $965 |
| Exemestane | Generic | 41 | 14 | $10,520 |
Hospital affiliations
Frequently asked questions
What is Dr. Ashley Fry's medical specialty?
Dr. Ashley Fry practices Hematology & Oncology Physician in Birmingham, AL.
Where does Dr. Ashley Fry practice?
Dr. Ashley Fry practices at 2728 10Th Ave S Ste 200, Birmingham, AL 352051202. Office phone: 2059397880.
What is Dr. Ashley Fry's NPI?
Dr. Ashley Fry's National Provider Identifier (NPI) is 1184941460, issued by NPPES.
Does Dr. Ashley Fry accept Medicare assignment?
Yes. Dr. Ashley Fry accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashley Fry commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, immune globulin (bivigam), 500 mg (HCPCS J1556). Source: CMS Medicare Physician & Other Practitioners file.